Canadians with cancer spend an average $33K out of pocket for medical care: report

Vanessa Percoco faced a difficult decision during her battle with cancer – pay for treatments to feel better or prioritize paying rent. The 33-year-old from Laval, Que., was working in special education when she received a devastating diagnosis of advanced colorectal cancer in 2022, putting her career plans on hold.

Over the course of more than two years of treatment, including surgery and chemotherapy, Percoco spent over $4,000 on prescription medications, colostomy bags, bandages, physiotherapy, osteopathic consultations, and other expenses. Unable to work due to her diagnosis, she quickly exhausted her 15 weeks of employment insurance and had to rely on financial support from loved ones.

“When you’re going through cancer treatment, you should be focused on surviving and feeling better,” Percoco shared with CBC News. “Instead, I was constantly worried about money. I had to pay to get better.”

The Canadian Cancer Society highlighted Percoco’s story in a recent report on the financial costs of cancer treatment. While hospital procedures like surgery and chemotherapy are publicly covered, the average cancer patient faces nearly $33,000 in expenses over their lifetime. These costs include out-of-pocket expenditures for medications, transportation to medical facilities, accommodation, as well as lost income during treatment and recovery.

The report, co-chaired by Ioana Nicolau, utilized a modeling tool in collaboration with Statistics Canada and the Public Health Agency of Canada to estimate these expenses. The most commonly diagnosed cancers in Canada – breast, colorectal, lung, and prostate – are projected to have a significant economic impact on healthcare systems, accounting for $14.2 billion in costs this year.

Individuals bear 20% of the total societal cost, with the remaining balance attributed to direct health system expenses. Nicolau emphasized that financial constraints can lead some patients to delay or forego essential aspects of their treatment, potentially impacting their health outcomes.

Dr. Christopher Booth, a medical oncologist and professor, highlighted the report’s focus on personal stories and the financial barriers that affect patients’ care. The burden of costs borne by patients and families is a concerning finding that underscores the need to address systemic shortcomings.

Percoco expressed gratitude for the support of her family during her treatment, emphasizing the critical role they played in her journey. Financial aid for travel-related expenses is available through organizations like the Canadian Cancer Society, offering relief to patients facing financial strain.

Nicolau hopes that the report sparks dialogue and prompts policymakers to address the financial challenges faced by individuals battling cancer. For Percoco, returning to work in special education was a significant milestone, driven by a desire to share her story and advocate for others facing similar struggles.

The report sheds light on the hidden costs of cancer treatment and underscores the importance of finding solutions to alleviate the financial burden on patients fighting for their lives.